Neuroplasticity-enhancing therapy using glia-like cells derived from human mesenchymal stem cells for the recovery of sequelae of cerebral infarction
RNA-seq data of human mesenchymal stem cells (hMSCs) and their induced toward glia-like cells (ghMSCs)